SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ladyPI who wrote (50135)2/8/2019 6:17:33 AM
From: patlawche111 Recommendation

Recommended By
idahoranch1

  Read Replies (2) of 63284
 
>I think the best decision they could make is to sell the company, sooner rather than later<

I can't imagine where the status of 132 is right now, that the premium for selling the company sooner rather than later would get us past or even close to the highs of last August. They need to right the ship IMHO.

Data to date on 132 in all indications has been remarkably consistent, although a risk, I personally am not concerned the Ascent P3 will disappoint, and with Samsung expected to be approved next year for production, I'm patient and can wait till 2020 and beyond for this mess to untangle itself.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News